Liver‐specific deletion of microRNA ‐34a alleviates ductular reaction and liver fibrosis during experimental cholestasis
Liver‐specific deletion of microRNA ‐34a alleviates ductular reaction and liver fibrosis during experimental cholestasis
复制标题
肝脏特异性删除 microRNA 34a 可减轻实验性胆汁淤积期间的导管反应和肝纤维化
DOI:
10.1096/fj.202201453r
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
Fanyin Meng
中科院分区:
文献类型:
--
作者:
Ying Wan;Tianhao Zhou;Elise Slevin;Sachiko Koyama;Xuedong Li;Kelly Harrison;Tian Li;Bingru Zhou;Sugeily Ramos Lorenzo;Yudian Zhang;Wenjuan Xu;James E. Klaunig;Chaodong Wu;Ashok K. Shetty;Chiung‐Kuei Huang;Fanyin Meng
Primary sclerosing cholangitis (PSC) is a chronic liver disease characterized by inflammatory responses and fibrotic scar formation leading to cholestasis. Ductular reaction and liver fibrosis are typical liver changes seen in human PSC and cholestasis patients. The current study aimed to clarify the role of liver‐specific microRNA‐34a in the cholestasis‐associated ductular reaction and liver fibrosis. We demonstrated that miR‐34a expression was significantly increased in human PSC livers along with the enhanced ductular reaction, cellular senescence, and liver fibrosis. A liver‐specific miR‐34a knockout mouse was established by crossing floxed miR‐34a mice with albumin‐promoter‐driven Cre mice. Bile duct ligation (BDL) induced liver injury characterized by necrosis, fibrosis, and immune cell infiltration. In contrast, liver‐specific miR‐34a knockout in BDL mice resulted in decreased biliary ductular pathology associated with the reduced cholangiocyte senescence and fibrotic responses. The miR‐34a‐mediated ductular reactions may be functioning through Sirt‐1‐mediated senescence and fibrosis. The hepatocyte‐derived conditioned medium promoted LPS‐induced fibrotic responses and senescence in cholangiocytes, and miR‐34a inhibitor suppressed these effects, further supporting the involvement of paracrine regulation. In conclusion, we demonstrated that liver‐specific miR‐34a plays an important role in ductular reaction and fibrotic responses in a BDL mouse model of cholestatic liver disease.